Skip to content

To assess the Vajikarana effect of Vrishya Pupalika and Modak against placebo.

A randomized controlled study to assess the Vajikarana effect of Vrishya Pupalika and Modak against placebo.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023272
Enrollment
30
Registered
2020-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Vrishya modak: Group B will be given Vrishya modak 1 pala or 48 grams once a day orally with anupana of sharkara yukta dugdha for 3 month along with healthy sexual life style. Interven

Sponsors

National Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy married males between 25 to 45 years of age will be included.

Exclusion criteria

Exclusion criteria: Any systematic disease like Diabetes, Hypertension, Mental problems, etc.

Design outcomes

Primary

MeasureTime frame
Change in IIEF-15 Patient questionnaireTimepoint: 3 Month

Secondary

MeasureTime frame
Change in Semen analysisTimepoint: 3 Month

Countries

India

Contacts

Public ContactDr Sukh Ram

National Institute of Ayurveda

dvd6197@gmail.com9929564660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026